Team:Tufts/future

From 2014.igem.org

(Difference between revisions)
Line 62: Line 62:
<br><br>
<br><br>
       <hr class="featurette-divider">
       <hr class="featurette-divider">
-
 
</div>
</div>
-
<!--
 
-
<h4>Summary </h4>
 
-
The conference incorporates two main events. The first is a professional workshop, to be held
 
-
under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage
 
-
application and associated safety and regulatory considerations. This will be followed by a public
 
-
forum to present and discuss the results and implications with a more general audience before
 
-
shifting to guided and informal discussion. <br>
 
-
<h4>Public Forum </h4>
 
-
1. Opening Remarks – President Anthony Monaco <br>
 
-
2. Biology of Phage – Tufts Synthetic Biology <br>
 
-
3. Phage History & Current Use – Anna Kuchment <br>
 
-
4. Current Research: Natural Phage – Dr. Andrew Camilli <br>
 
-
5. Current Research: Engineered Phage – Mark Mimee <br>
 
-
6. Distributive Justice – Christopher Ghadban <br>
 
-
--- Intermission --- <br>
 
-
7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee <br>
 
-
-->
 
<object width="100%" height="600px" data="https://static.igem.org/mediawiki/2014/c/c5/Tufts_conference.pdf"> </object>
<object width="100%" height="600px" data="https://static.igem.org/mediawiki/2014/c/c5/Tufts_conference.pdf"> </object>
</div>
</div>
</html>
</html>

Revision as of 20:28, 17 October 2014

Tufts University



This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.

Application Scenarios

Techno-Moral Scenarios

Survey



Retrieved from "http://2014.igem.org/Team:Tufts/future"